SS Innovations International Inc. (NASDAQ: SSII) reported record first-quarter 2026 financial results, with revenue surging 116.8% year over year to $11.1 million, driven by accelerating adoption of its SSi Mantra surgical robotic system. The company's installed base reached 194 systems across 11 countries, and cumulative robotic procedures totaled nearly 9,750 during the quarter, underscoring strong commercial momentum.
The company's gross profit rose to $5.3 million from $1.1 million in the prior-year period, reflecting improved operational efficiency and higher procedure volumes. SS Innovations also achieved several regulatory milestones, securing approvals in Sri Lanka, Kenya, Indonesia, and the Philippines, which expanded its international market access during the quarter.
In a landmark demonstration of its remote surgery platform, SS Innovations completed the world's longest-distance robotic cardiac telesurgery, showcasing the potential of telesurgery to bridge healthcare gaps in underserved regions. The company continues to pursue regulatory clearance in both the United States and Europe while strengthening its presence in emerging healthcare markets.
As of June 22, 2026, the cumulative number of multi-specialty procedures performed with the SSi Mantra system reached 11,719, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. Approximately 2,100 physicians have been trained on the system, which has been used for over 170 different procedure types.
For more information, visit the company's website at www.SSInnovations.com.
